Epidemiology and Surveillance of Foodborne Pathogens and Antimicrobial Resistance

A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Mechanism and Evolution of Antibiotic Resistance".

Deadline for manuscript submissions: closed (15 April 2022) | Viewed by 8902

Special Issue Editors


E-Mail Website
Guest Editor
Department of Public Health Policy, School of Public Health, University of West Attica, 115 21 Athens, Greece
Interests: food-borne pathogens; antibiotic resistance; Public Health Microbiology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Directorate of Epidemiological Surveillance for Infectious Diseases, National Public Health Organization (EODY), 15123 Athens, Greece
Interests: foodborne and waterborne diseases; vectorborne diseases; zoonoses; surveillance and epidemiology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Foodborne pathogens, even after amazing technological progress in the agriculture, livestock and food industry, continue to be a major public health issue, especially due to the increasing antimicrobial resistance in pathogens commonly transmitted by food. Surveillance of antimicrobial resistance bacteria permits the early detection of resistant strains, the identification of outbreaks and the implementation of public health measures. Surveillance data are also important for informing clinical therapy decisions.

WHO has issued guidance for the establishment of integrated surveillance systems of antimicrobial resistance in the foodborne bacteria by taking a One Health approach. Still, there is a diversity of surveillance systems in place and of specific outputs. The present Special Issue aims to address the variability of surveillance methods used (in humans and animals) and to summarize the most recent evidence on the evolution of antimicrobial resistance of foodborne pathogens, such as Campylobacter spp., Salmonella spp., Yersinia enterocolitica, pathogenic Escherichia coli and Listeria monocytogenes. Finally, papers written under the prism of One Health, combining data from different data sources (human, food and animal), are welcomed, in order to have a more holistic view of the resistance of foodborne pathogens in different parts of the food chain. If serious foodborne outbreaks occur during the preparation period of this Special Issue, they are also welcomed to be presented.

Dr. Georgia Mandilara
Dr. Kassiani Mellou
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • epidemiology and surveillance
  • foodborne pathogens
  • foodborne outbreaks
  • antimicrobial resistance
  • Campylobacter spp.
  • Salmonella spp.
  • Yersinia enterocolitica
  • pathogenic Escherichia coli
  • Listeria monocytogenes
  • One Health approach

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 598 KiB  
Article
Colistin Resistance Mechanisms in Human Salmonella enterica Strains Isolated by the National Surveillance Enter-Net Italia (2016–2018)
by Daniela Fortini, Slawomir Owczarek, Anna Maria Dionisi, Claudia Lucarelli, Sergio Arena, Alessandra Carattoli, Enter-Net Italia Colistin Resistance Study Group, Laura Villa and Aurora García-Fernández
Antibiotics 2022, 11(1), 102; https://doi.org/10.3390/antibiotics11010102 - 13 Jan 2022
Cited by 13 | Viewed by 2796
Abstract
Background: A collection of human-epidemiologically unrelated S. enterica strains collected over a 3-year period (2016 to 2018) in Italy by the national surveillance Enter-Net Italia was analysed. Methods: Antimicrobial susceptibility tests, including the determination of minimal inhibitory concentrations (MICs) for colistin, were performed. [...] Read more.
Background: A collection of human-epidemiologically unrelated S. enterica strains collected over a 3-year period (2016 to 2018) in Italy by the national surveillance Enter-Net Italia was analysed. Methods: Antimicrobial susceptibility tests, including the determination of minimal inhibitory concentrations (MICs) for colistin, were performed. Colistin resistant strains were analysed by PCR to detect mobile colistin resistance (mcr) genes. In mcr-negative S. enterica serovar Enteritidis strains, chromosomal mutations potentially involved in colistin resistance were identified by a genomic approach. Results: The prevalence of colistin-resistant S. enterica strains was 7.7%, the majority (87.5%) were S. Enteritidis. mcr genes were identified only in one strain, a S. Typhimurium monophasic variant, positive for both mcr-1.1 and mcr-5.1 genes in an IncHI2 ST4 plasmid. Several chromosomal mutations were identified in the colistin-resistant mcr-negative S. Enteritidis strains in proteins involved in lipopolysaccharide and outer membrane synthesis and modification (RfbN, LolB, ZraR) and in a component of a multidrug efflux pump (MdsC). These mutated proteins were defined as possible candidates for colistin resistance in mcr-negative S. Enteritidis of our collection. Conclusions: The colistin national surveillance in Salmonella spp. in humans, implemented with genomic-based surveillance, permitted to monitor colistin resistance, determining the prevalence of mcr determinants and the study of new candidate mechanisms for colistin resistance. Full article
Show Figures

Figure 1

15 pages, 18862 KiB  
Article
Investigation of the Genes Involved in the Outbreaks of Escherichia coli and Salmonella spp. in the United States
by Michelle Li, Kyle Wang, Ashley Tang, Aaron Tang, Andrew Chen and Zuyi Huang
Antibiotics 2021, 10(10), 1274; https://doi.org/10.3390/antibiotics10101274 - 19 Oct 2021
Cited by 7 | Viewed by 2883
Abstract
Salmonella spp. and Escherichiacoli (E. coli) are two of the deadliest foodborne pathogens in the US. Genes involved in antimicrobial resistance, virulence, and stress response, enable these pathogens to increase their pathogenicity. This study aims to examine the genes detected [...] Read more.
Salmonella spp. and Escherichiacoli (E. coli) are two of the deadliest foodborne pathogens in the US. Genes involved in antimicrobial resistance, virulence, and stress response, enable these pathogens to increase their pathogenicity. This study aims to examine the genes detected in both outbreak and non-outbreak Salmonella spp. and E. coli by analyzing the data from the National Centre for Biotechnology Information (NCBI) Pathogen Detection Isolates Browser database. A multivariate statistical analysis was conducted on the genes detected in isolates of outbreak Salmonella spp., non-outbreak Salmonella spp., outbreak E. coli, and non-outbreak E. coli. The genes from the data were projected onto a two-dimensional space through principal component analysis. Hierarchical clustering was then used to quantify the relationship between the genes in the dataset. Most of the outlier genes identified in E. coli isolates are virulence genes, while outlier genes identified in Salmonella spp. are mainly involved in stress response. Gene epeA, which encodes a high-molecular-weight serine protease autotransporter of Enterobacteriaceae (SPATE) protein, along with subA and subB that encode cytotoxic activity, may contribute to the pathogenesis of outbreak E. coli. The iro operon and ars operon may play a role in the ecological success of the epidemic clones of Salmonella spp. Concurrent relationships between esp and ter operons in E. coli and pco and sil operons in Salmonella spp. are found. Stress-response genes (asr, golT, golS), virulence gene (sinH), and antimicrobial resistance genes (mdsA and mdsB) in Salmonella spp. also show a concurrent relationship. All these findings provide helpful information for experiment design to combat outbreaks of E. coli and Salmonella spp. Full article
Show Figures

Figure 1

11 pages, 1168 KiB  
Article
Diversity and Resistance Profiles of Human Non-typhoidal Salmonella spp. in Greece, 2003–2020
by Kassiani Mellou, Mary Gkova, Emily Panagiotidou, Myrsini Tzani, Theologia Sideroglou and Georgia Mandilara
Antibiotics 2021, 10(8), 983; https://doi.org/10.3390/antibiotics10080983 - 15 Aug 2021
Cited by 14 | Viewed by 2415
Abstract
Salmonella spp. is one of the most common foodborne pathogens in humans. Here, we summarize the laboratory surveillance data of human non-typhoidal salmonellosis in Greece for 2003–2020. The total number of samples declined over the study period (p < 0.001). Of the [...] Read more.
Salmonella spp. is one of the most common foodborne pathogens in humans. Here, we summarize the laboratory surveillance data of human non-typhoidal salmonellosis in Greece for 2003–2020. The total number of samples declined over the study period (p < 0.001). Of the 193 identified serotypes, S. Enteritidis was the most common (52.8%), followed by S. Typhimurium (11.5%), monophasic S. Typhimurium 1,4,[5],12:i:- (4.4%), S. Bovismorbificans (3.4%) and S. Oranienburg (2.4%). The isolation rate of S. Enteritidis declined (p < 0.001), followed by an increase of the less common serotypes. Monophasic S. Typhimurium has been among the five most frequently identified serotypes every year since it was first identified in 2007. Overall, Salmonella isolates were resistant to penicillins (11%); aminoglycosides (15%); tetracyclines (12%); miscellaneous agents (sulphonamides, trimethoprim, chloramphenicol and streptomycin) (12%) and third-generation cephalosporins (2%). No isolate was resistant to carbapenems. In total, 2070 isolates (24%) were resistant to one or two antimicrobial classes and 903 (10%) to three and more. Out of the 1166 isolates resistant to fluoroquinolones (13%), 845 (72%) were S. Enteritidis. S. Enteritidis was also the most frequently identified serotype with a resistance to third-generation cephalosporins (37%, 62/166), followed by S. Typhimurium (12%, 20/166). MDR was most frequently identified for S. Typhimurium and its monophasic variant (resistant phenotype of ampicillin, streptomycin, tetracycline and sulphamethoxazole with or without chloramphenicol or trimethoprim). Full article
Show Figures

Figure 1

Back to TopTop